Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

25. März 2015 12:21 ET | Quelle: Trinity Biotech plc

Trinity Biotech Announces Filing of 2014 Annual Report

DUBLIN, March 25, 2015 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today...
03. März 2015 08:47 ET | Quelle: Trinity Biotech plc

Trinity Biotech Announces Results for Q4 and Fiscal Year 2014

DUBLIN, Ireland, March 3, 2015 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets,...
25. Februar 2015 10:44 ET | Quelle: Trinity Biotech plc

Trinity Biotech plc to Announce Fourth Quarter and Fiscal Year 2014 Financial Results

DUBLIN, Feb. 25, 2015 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will...
23. Februar 2015 10:18 ET | Quelle: Trinity Biotech plc

Trinity Biotech Announces Recommencement of US Clinical Trials on Its Point-of-Care, High Sensitivity Troponin I Product

DUBLIN, Ireland, Feb. 23, 2015 (GLOBE NEWSWIRE) -- Trinity Biotech plc. (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory...
16. Dezember 2014 11:26 ET | Quelle: Trinity Biotech plc

Trinity Biotech Announces CLIA Waiver of Rapid Syphilis Test

DUBLIN, Ireland, Dec. 16, 2014 (GLOBE NEWSWIRE) -- Trinity Biotech plc. (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory...
23. Oktober 2014 09:01 ET | Quelle: Trinity Biotech plc

Trinity Biotech Announces Quarter 3 Financial Results and Temporary Suspension of Meritas Troponin Trials

DUBLIN, Ireland, Oct. 23, 2014 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets,...
06. Oktober 2014 05:45 ET | Quelle: Trinity Biotech plc

Trinity Biotech plc to Announce Third Quarter Fiscal 2014 Financial Results

DUBLIN, Oct. 6, 2014 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will...
25. September 2014 06:24 ET | Quelle: Trinity Biotech plc

Trinity Biotech Announces CE Marking of New Meritas Heart Failure (BNP) Point-of-Care Test

DUBLIN, Sept. 25, 2014 (GLOBE NEWSWIRE) -- Trinity Biotech plc. (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today...
29. Juli 2014 07:57 ET | Quelle: Trinity Biotech plc

Trinity Biotech Announces Quarter 2 Financial Results; 25% Increase in Operating Profits

DUBLIN, July 29, 2014 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today...
21. Juli 2014 05:31 ET | Quelle: Trinity Biotech plc

Trinity Biotech plc to Announce Second Quarter Fiscal Year 2014 Financial Results

DUBLIN, July 21, 2014 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will...

Vorherige Seite